7 / 101
F
resh
and
good
news
R
ev
A
ssoc
M
ed
B
ras
2015; 61(5):389
389
EDITORIAL
Fresh and good news
N
ovas
e
boas
notícias
C
arlos
V. S
errano
J
r
.
1
1
Editor-in-Chief,
Journal of the Brazilian Medical Association
(
Ramb, Revista da Associação Médica Brasileira
), São Paulo, SP, Brazil
http://dx.doi.org/10.1590/1806-9282.61.05.389In the last edition of 2014, we used this very section to
discuss the
Journal of the Brazilian Medical Association’s
(
Ramb,
Revista da Associação Médica Brasileira
) new pathways,
through an editorial in which we presented plans aiming
at its consolidation among the country’s most relevant
scientific publications.
Today, almost a year later, we have something to cel-
ebrate. There has been an increase in
Ramb’s
impact fac-
tor: from 0.915, as measured in 2013, to 0.933 in 2014, a
result that places
Ramb
among the 20 most cited Brazil-
ian journals. This information was reported by the
Jour-
nal Citation Reports
(JCR) and published by the ISI WEB
of Knowledge portal page on June 18, based on citation
statistics of 2014. This is the second consecutive year that
Ramb
grows in impact factor. In 2012,
Ramb’s
impact fac-
tor calculated using the same criteria adopted by the JCR
was 0.771, that is,
Ramb
has increased its number of cita-
tions by 0.162 in just two years.
The impact factor is known to be a measure that dem-
onstrates the average number of citations of scientific ar-
ticles published in a given journal, serving as a parame-
ter to evaluate and compare journals from a common
area. The higher the impact factor of a journal, the bet-
ter its chances of having an article cited. In addition to
the JCR (Science Citation), which assesses journals,
Ramb
is also included in the SJR SCImago (Journal & Country
Rank, Scopus/Elsevier database), with 0,267 (2013) indi-
cator value, and ranked as Qualis/Capes category B2. It
is also indexed on the Lilacs, PubMed (Medline), Scopus
and SciELo databases.
This result is important for
Ramb
and shows that we
are on track towards increasing its reach year after year.
We believe that strategies such as the plan to issue a month-
ly journal, to prepare special themed editions, reformu-
late the current proofreading process and change the sub-
mission process to give more flexibility to the development
of articles can help to raise even more this impact factor.
Thus, since the beginning of August,
Ramb
has a new
article submission mechanism. It is called ScholarOne, a
platform certified by SciELO through a partnership with
Thomson Reuters, one of the most reputable scientific
information platforms, employed by journals through-
out the world.
The advantages that ScholarOne provides authors and
us, editors administratively, greatly optimizing the flow of
articles, will allow
Ramb
to gain more agility, favoring all.
The ScholarOne is currently used by over 500 institu-
tions, 3,400 journals worldwide, supporting over 13 mil-
lion users. In addition to features that significantly reduce
time in the flowchart of submissions, it offers plagiarism
detection, automated citation hyperlink to PubMed, send-
ing of multimedia files, and online database FAQ, allow-
ing research various subjects for basic submission tasks.
Access to the platform is done through the new
Ramb
website
(www.ramb.org.br), launched last May. By clicking
on
submit article
, in the main menu, the author will be re-
directed to the ScholarOne platform. In addition to this
facility, the new website is more up-to-date, with a sleek
enjoyable look, as well as quite objective. It features search
tools to previous editions of
Ramb
, which from this point
on will be available online only, together with all the ma-
terial made available to date by the SciELo. There is also a
section to present news, links to other clinical guidelines
produced by the Brazilian Medical Association (AMB, As-
sociação Médica Brasileira) and specialties, norms for the
publication of journal supplements, norms to write arti-
cles, and online access for article submission.
We hope to return soon to this section with fresh and
good news, not only for
Ramb
, but for the Brazilian sci-
entific community that believes in our work.